Do you have to take weight loss injections for life?

Do the injections have a fixed end date, or do you take them indefinitely?

There is no single answer that fits everyone, which is genuinely the most useful starting point. The licensed medicines (Mounjaro and Wegovy) are approved for weight management in adults alongside a reduced-calorie diet and increased activity, but the UK licences do not specify a hard stop date. What gives the clearest steer is NICE's guidance. For semaglutide (Wegovy), NICE's technology appraisal TA875 recommends its use for a maximum of two years within specialist NHS weight management services, and advises reviewing whether to continue if less than 5% weight loss is achieved after six months at the maintenance dose. For tirzepatide (Mounjaro), NICE TA1026 sets a similar review trigger at the six-month mark on the highest tolerated dose, though it does not set the same two-year ceiling.

Private prescribers follow the same clinical evidence but have more flexibility to work with you individually. If you are trying to understand how long you are likely to have to take weight loss injections, the answer depends on your individual goals, your response to treatment, and ongoing clinical reviews. Others find that ongoing treatment continues to support their health. Neither path is automatically right.

The key practical point: your prescriber reviews your treatment before every repeat order. At nume, that review happens before each repeat, there is no automatic renewal, and no dose changes without a fresh clinical look. That structure means treatment length stays an active conversation rather than a quiet default.

What actually happens to weight when you stop taking the injections?

This is the question people ask in hushed tones, and it deserves a straight answer. The trial data are clear: weight regain is common after stopping GLP-1 medicines. In the STEP 1 trial of semaglutide, participants who discontinued treatment after 68 weeks regained a substantial portion of the weight they had lost over the following year. Tirzepatide trial extensions show a similar pattern.

That is not a judgement on anyone's effort. Obesity is a chronic condition influenced by biology (hormones, appetite signalling, metabolic rate) not a temporary problem fixed by a course of tablets. When a medicine that lowers appetite and slows gastric emptying is withdrawn, those biological pressures return. Knowing this in advance lets you and your prescriber plan: what lifestyle foundations are in place, whether a maintenance approach is realistic, and what monitoring makes sense after stopping.

If you are wondering whether you have to stay on weight loss injections forever, there is more detail on that question separately. The honest summary is that stopping abruptly without a plan is less likely to lead to a good long-term outcome than a structured, discussed transition.

Are there people who do stay on the injections long-term?

Yes. For some people, particularly those with significant weight-related health conditions such as type 2 diabetes, hypertension or obstructive sleep apnoea, the clinical case for continuing treatment beyond two years is strong. Obesity is increasingly treated as a chronic condition, the same way a GP might continue blood-pressure medication rather than stopping once numbers improve. Whether that applies to you is a question for your prescriber, who can weigh up your comorbidities, your response to treatment and your preferences.

There is a related question, which is whether you are even suitable for long-term use, and what monitoring that involves. The answer varies: it requires ongoing prescriber oversight, regular evidence of your current weight and health, and a genuine clinical rationale. It is not simply a matter of continuing to order repeat pens.

If cost is part of your thinking when weighing up longer treatment, the treatment page shows what is included in one transparent price, no subscription, no hidden fees. Worth knowing before you plan.

What should you do if you want to stop, or are thinking about it?

Tell your prescriber before stopping, rather than simply not reordering. This matters for two reasons. First, an abrupt stop without a plan leaves a gap, no dose tapering is required medically, but having a conversation about what replaces the appetite and satiety support the medicine was providing means you are not navigating that alone. Second, your prescriber can record the decision, update your GP if appropriate, and give you clear guidance on what to watch for.

If you are on tirzepatide, the NHS medicines guidance for tirzepatide and the Patient Information Leaflet are both worth reading before any change. For semaglutide, the equivalent NHS page covers the same ground. Neither replaces a conversation, they complement it.

You can explore who these medicines are suitable for and whether you would be eligible for a private prescription before committing to anything. And if you have questions that do not fit neatly into a form, our FAQs cover many of the most common ones. When you are ready to talk it through with a prescriber, a free consultation with a weight loss injection prescriber is the natural next step.